BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 30920161)

  • 1. Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature review.
    Kumar A; Zastrow DB; Kravets EJ; Beleford D; Ruzhnikov MRZ; Grove ME; Dries AM; Kohler JN; Waggott DM; Yang Y; Huang Y; ; Mackenzie KM; Eng CM; Fisher PG; Ashley EA; Teng JM; Stevenson DA; Shieh JT; Wheeler MT; Bernstein JA
    Am J Med Genet A; 2019 Jun; 179(6):966-977. PubMed ID: 30920161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mosaic Activating Mutations in GNA11 and GNAQ Are Associated with Phakomatosis Pigmentovascularis and Extensive Dermal Melanocytosis.
    Thomas AC; Zeng Z; Rivière JB; O'Shaughnessy R; Al-Olabi L; St-Onge J; Atherton DJ; Aubert H; Bagazgoitia L; Barbarot S; Bourrat E; Chiaverini C; Chong WK; Duffourd Y; Glover M; Groesser L; Hadj-Rabia S; Hamm H; Happle R; Mushtaq I; Lacour JP; Waelchli R; Wobser M; Vabres P; Patton EE; Kinsler VA
    J Invest Dermatol; 2016 Apr; 136(4):770-778. PubMed ID: 26778290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic
    Zhang B; He R; Wu R; Yang Z; Hu M; Zhang N; Guo W; Xu Z; Ma L
    Pediatr Investig; 2024 Jun; 8(2):117-125. PubMed ID: 38910853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phacomatosis cesiomarmorata with hypospadias and phacomatosis cesioflammea with Sturge-Weber syndrome, Klippel-Trenaunay syndrome and aplasia of veins -- case reports with rare associations.
    Kaur T; Sharma N; Sethi A; Kooner S; Banger H
    Dermatol Online J; 2015 Sep; 21(9):. PubMed ID: 26437284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phacomatosis pigmentovascularis: Report of four new cases.
    Nanda A; Al-Abdulrazzaq HK; Habeeb YK; Zakkiriah M; Alghadhfan F; Al-Noun R; Al-Ajmi H
    Indian J Dermatol Venereol Leprol; 2016; 82(3):298-303. PubMed ID: 27088932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phacomatosis spilorosea versus phacomatosis melanorosea: a critical reappraisal of the worldwide literature with updated classification of phacomatosis pigmentovascularis.
    Torchia D
    Acta Dermatovenerol Alp Pannonica Adriat; 2021 Mar; 30(1):27-30. PubMed ID: 33765754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phacomatosis pigmentovascularis revisited and reclassified.
    Happle R
    Arch Dermatol; 2005 Mar; 141(3):385-8. PubMed ID: 15781681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phacomatosis pigmentovascularis type 2b (phacomatosis cesioflammea) with double superior vena cava, abdominal varicosities, and natal tooth: Novel associations.
    Singal A; Mittal H; Aggarwal A; Das S; Manchanda S
    Pediatr Dermatol; 2018 May; 35(3):e151-e154. PubMed ID: 29479730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phakomatosis pigmentovascularis cesioflammea: a case report].
    Viada Peláez MC; Stefano PC; Cirio A; Cervini AB
    Arch Argent Pediatr; 2018 Feb; 116(1):e121-e124. PubMed ID: 29333836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red-white and blue baby: a case of phacomatosis pigmentovascularis type V.
    Byrom L; Surjana D; Yoong C; Zappala T
    Dermatol Online J; 2015 Jun; 21(6):. PubMed ID: 26158369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of glaucoma associated with phacomatosis cesioflammea and phacomatosis cesioflammeo-marmorata.
    Huang S; Yang Y; Ouyang Z; Guo X; Zhan Z; Liu X; Chen Z; Xu J; Yu M
    Eur J Dermatol; 2022 Sep; 32(5):589-596. PubMed ID: 36468718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large aberrant Mongolian spots coexisting with cutis marmorata telangiectatica congenita (phacomatosis pigmentovascularis type V or phacomatosis cesiomarmorata).
    Torrelo A; Zambrano A; Happle R
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):308-10. PubMed ID: 16503893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phacomatosis pigmentovascularis of cesioflammea type in 7 patients: combination of ocular pigmentation (melanocytosis or melanosis) and nevus flammeus with risk for melanoma.
    Shields CL; Kligman BE; Suriano M; Viloria V; Iturralde JC; Shields MV; Say EA; Shields JA
    Arch Ophthalmol; 2011 Jun; 129(6):746-50. PubMed ID: 21670341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early-onset hypertension associated with extensive cutaneous capillary malformations harboring postzygotic variants in GNAQ and GNA11.
    Davies OMT; Ng AT; Tran J; Blumenthal S; Arkin LM; Nopper AJ; Cottrell CE; Garzon M; Siegel DH; Frieden IJ; Drolet BA
    Pediatr Dermatol; 2022 Nov; 39(6):914-919. PubMed ID: 36440997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutis marmorata telangiectatica congenita being caused by postzygotic GNA11 mutations.
    Schuart C; Bassi A; Kapp F; Wieland I; Pagliazzi A; Losch H; Mazzatenta C; Bacci GM; Oranges T; Schanze D; Mohnike K; Nanda A; Fischer J; Zenker M; Happle R
    Eur J Med Genet; 2022 May; 65(5):104472. PubMed ID: 35351629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GNAQ/GNA11 Mosaicism Is Associated with Abnormal Serum Calcium Indices and Microvascular Neurocalcification.
    Knöpfel N; Zecchin D; Richardson H; Polubothu S; Barberan-Martin S; Cullup T; Gholam K; Heales S; Krywawych S; López-Balboa P; Muwanga-Nanyonjo N; Ogunbiyi O; Puvirajasinghe C; Solman L; Swarbrick K; Syed SB; Tahir Z; Tisdall MM; Allgrove J; Chesover AD; Aylett SE; Jacques TS; Hannan FM; Löbel U; Semple RK; Thakker RV; Kinsler VA
    J Invest Dermatol; 2024 Apr; 144(4):820-832.e9. PubMed ID: 37802294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Papillary Hemangioma Harbors Somatic GNA11 and GNAQ Mutations.
    Gestrich CK; Vivero MP; Konczyk DJ; Goss JA; Labow BI; Pearson GD; Cottrell CE; Mathew MT; Prasad V; Kozakewich HP; Fletcher CDM; Greene AK; Al-Ibraheemi A
    Am J Surg Pathol; 2024 Jan; 48(1):106-111. PubMed ID: 37750536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse Phenotyping in Patients with Skin Capillary Malformations and Mosaic GNAQ or GNA11 Mutations Defines a Clinical Spectrum with Genotype-Phenotype Correlation.
    Jordan M; Carmignac V; Sorlin A; Kuentz P; Albuisson J; Borradori L; Bourrat E; Boute O; Bukvic N; Bursztejn AC; Chiaverini C; Delobel B; Fournet M; Martel J; Goldenberg A; Hadj-Rabia S; Mahé A; Maruani A; Mazereeuw J; Mignot C; Morice-Picard F; Moutard ML; Petit F; Pasteur J; Phan A; Whalen S; Willems M; Philippe C; Vabres P
    J Invest Dermatol; 2020 May; 140(5):1106-1110.e2. PubMed ID: 31726051
    [No Abstract]   [Full Text] [Related]  

  • 19. Phacomatosis pigmentovascularis of cesioflammea type.
    Villarreal DJ; Leal F
    An Bras Dermatol; 2016; 91(5 suppl 1):54-56. PubMed ID: 28300894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monozygotic twins discordant for phacomatosis pigmentovascularis: evidence for the concept of twin spotting.
    Moutray T; Napier M; Shafiq A; Fryer A; Rankin S; Willoughby CE
    Am J Med Genet A; 2010 Mar; 152A(3):718-20. PubMed ID: 20186807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.